Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker

Fig. 1

Workflow of the study. Clarification of mechanisms of HCC with CYP2D6*10 polymorphisms and screening of potential biomarkers using label-free global proteome analysis. CYP2D6, cytochrome P4502D6. CC and TT refer to CYP2D6*10 CC or TT genotype patients. ANGPTL6, angiopoietin‐like 6. AUC, area under the curve. BP, biological processes. GO, gene ontology. Con, control. RNA-seq, RNA sequencing. HCC, hepatocellular carcinoma. ELISA, enzyme-linked immunosorbent assay. WB, western blotting. IHC, immunohistochemistry

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us